Luke Wander
Adjunct Associate Professor, Epidemiology
Associate Professor, Medicine - General Internal Medicine
Education
MD Medicine, University of Washington, 2008
Post-baccalaureate University of Washington, 2003
BFA Graphic Design and Computer Animation, Savannah College of Art and Design, 1997
MS Epidemiology, University of Washington, 2014
Research Areas
Research Interests
My collaborators and I combine the study of novel blood-based epigenetic biomarkers and established clinical/demographic measures to understand how diabetes develops. Our goal is to develop new biomarkers to find people at the highest risk of diabetes and its complications (prognostic biomarkers) and people likely to respond to interventions aimed at stopping disease progression (predictive biomarkers).
Recent Publications (PubMed)
(2025 Jun 20)
Diabetes Res Clin Pract
Avramovic S, Li X, Enquobahrie DA, Schwartz MD, Korpak A, Boyko EJ, Wander PL
(2025)
PLoS One 20(5): e0324709
Wander PL, Lowy E, Korpak A, Beste LA, Boyko EJ
(2025 May)
Health Aff Sch 3(5): qxaf080
Bui DP, Bast E, Trinh H, Fox A, Berkowitz TSZ, Palacio A, Wander PL, O'Hare AM, Boyko EJ, Ioannou GN, Maciejewski ML, Hynes DM
(2025 May 29)
J Public Health (Oxf) 47(2): 222-231
Wheeler SG, Beste LA, Overland MK, Wander PL
(2025)
PLoS One 20(2): e0317348
Wander PL, Lowy E, Korpak A, Beste LA, Kahn SE, Boyko EJ
Show complete publication list